Skip to main content

Advertisement

SpringerLink
Log in

Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The human leukocyte antigen DR surface expression on CD14+ monocytes reflects the degree to which these cells have been activated. Given the central role monocytes and macrophages play in the immune system, a decreased human leukocyte antigen DR expression on CD14+ monocytes results in a hallmark of altered immune status during systemic inflammatory response syndrome. We hypothesize that human leukocyte antigen DR expression might be similarly altered after hematopoietic stem cell transplantation and during post-transplant complications. Using flow cytometry, this study investigates the human leukocyte antigen DR surface expression of CD14+ monocytes in 30 pediatric and young adult patients up to 1 year after hematopoietic stem cell transplantation. Normal values were derived from a control group of healthy children, adolescents, and young adults. Human leukocyte antigen DR expression decreased significantly prior and during bacterial infection or sepsis. By contrast, human leukocyte antigen DR expression levels were elevated before and at the time of viremia. Human leukocyte antigen DR expression was also elevated during acute graft-versus-host disease. In contrast, the expression was reduced when patients had hepatic veno-occlusive disease. A significant decrease of human leukocyte antigen DR expression was associated with a relapse of the underlying disease and before death. Human leukocyte antigen DR expression on CD14+ monocytes appears to be a promising parameter that might allow identification of patients at risk after hematopoietic stem cell transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN, Kiehn TE, Pamer E, Papanicolaou GA (2005) Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transplant infect dis : off j Transplant Soc 7(1):11–17. doi:10.1111/j.1399-3062.2005.00088.x

    Article  CAS  Google Scholar 

  2. Bearman SI (2001) Avoiding hepatic veno-occlusive disease: what do we know and where are we going? Bone Marrow Transplant 27(11):1113–1120

    Article  CAS  PubMed  Google Scholar 

  3. Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373(9674):1550–1561. doi:10.1016/s0140-6736(09)60237-3

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y, Okamoto T, Suehiro A, Kanamaru A, Kakishita E (2000) Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 26(4):419–426. doi:10.1038/sj.bmt.1702517

    Article  CAS  PubMed  Google Scholar 

  5. Docke WD, Hoflich C, Davis KA, Rottgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, Nebe T, Engel A, Monneret G, Spittler A, Schmolke K, Reinke P, Volk HD, Kunz D (2005) Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 51(12):2341–2347. doi:10.1373/clinchem.2005.052639

    Article  PubMed  Google Scholar 

  6. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3(6):678–681

    Article  CAS  PubMed  Google Scholar 

  7. Monneret G, Finck ME, Venet F, Debard AL, Bohe J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95(2):193–198. doi:10.1016/j.imlet.2004.07.009

    Article  CAS  PubMed  Google Scholar 

  8. Wolk K, Kunz S, Crompton NE, Volk HD, Sabat R (2003) Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J biol chem 278(20):18030–18036. doi:10.1074/jbc.M207714200

    Article  CAS  PubMed  Google Scholar 

  9. Perry SE, Mostafa SM, Wenstone R, Shenkin A, McLaughlin PJ (2003) Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med 29(8):1245–1252. doi:10.1007/s00134-003-1686-2

    Article  PubMed  Google Scholar 

  10. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ (1993) Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br j of surg 80(2):205–209

    Article  CAS  Google Scholar 

  11. Kanakoudi-Tsakalidou F, Debonera F, Drossou-Agakidou V, Sarafidis K, Tzimouli V, Taparkou A, Kremenopoulos G (2001) Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection. Clin Exp Immunol 123(3):402–407

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA (2004) Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 11(1):161–167

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H (2004) Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188(2):150–156. doi:10.1016/j.amjsurg.2003.12.067

    Article  CAS  PubMed  Google Scholar 

  14. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr crit care med : j Soc Crit Care Med World Fed Pediatr Intensiv Crit Care Soc 6(1):2–8. doi:10.1097/01.pcc.0000149131.72248.e6

    Article  Google Scholar 

  15. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295–304

    Article  CAS  PubMed  Google Scholar 

  16. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44(6):778–783

    Article  CAS  PubMed  Google Scholar 

  17. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatol (Baltim, Md) 4(1):116–122

    Article  CAS  Google Scholar 

  18. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118(4):255–267

    Article  CAS  PubMed  Google Scholar 

  19. Hill GR, Teshima T, Gerbitz A, Pan L, Cooke KR, Brinson YS, Crawford JM, Ferrara JL (1999) Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 104(4):459–467. doi:10.1172/jci6896

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB (1994) Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83(8):2360–2367

    CAS  PubMed  Google Scholar 

  21. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br j surg 77(2):204–207

    Article  CAS  PubMed  Google Scholar 

  22. Genel F, Atlihan F, Ozsu E, Ozbek E (2010) Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J infect 60(3):224–228. doi:10.1016/j.jinf.2009.12.004

    Article  PubMed  Google Scholar 

  23. Faivre V, Lukaszewicz AC, Alves A, Charron D, Payen D, Haziot A (2007) Accelerated in vitro differentiation of blood monocytes into dendritic cells in human sepsis. Clin Exp Immunol 147(3):426–439. doi:10.1111/j.1365-2249.2006.03287.x

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Yang HM, Yu Y, Chai JK, Hu S, Sheng ZY, Yao YM (2008) Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro. Burn : j Int Soc Burn Inj 34(8):1158–1162. doi:10.1016/j.burns.2008.01.026

    Article  Google Scholar 

  25. Soukup JM, Becker S (2003) Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro. Clinl immunol (Orlando, Fla) 107(3):178–185

    Article  CAS  Google Scholar 

  26. Fowler DH, Foley J, Whit-Shan Hou J, Odom J, Castro K, Steinberg SM, Gea-Banacloche J, Kasten-Sportes C, Gress RE, Bishop MR (2004) Clinical “cytokine storm” as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin gastroenterol hepatol : off clin pract j Am Gastroentero Assoc 2(3):237–245

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interests.

Author information

Authors and Affiliations

  1. Department I – General Paediatrics, Hematology/Oncology, University Children’s Hospital Tübingen, Hoppe-Seyler-Str. 1, 72076, Tübingen, Germany

    Michaela Döring, Karin Melanie Rohrer, Annika Erbacher, Carl-Philipp Schwarze & Rupert Handgretinger

  2. Research Institute Children’s Cancer Center Hamburg, Martinistr. 52, 20246, Hamburg, Germany

    Friederike Gieseke

  3. Department of Pediatric Hematology and Oncology, University Children’s Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Peter Bader

  4. Department II – Paediatric Cardiology, Pulmology, Intensive Care Medicine, University Children’s Hospital Tübingen, Hoppe-Seyler-Str.1, 72076, Tübingen, Germany

    Michael Hofbeck

  5. Department of Pediatric Cardiology, University Children’s Hospital Gießen, Feulegenstr.12, 35390, Gießen, Germany

    Gunter Kerst

Authors
  1. Michaela Döring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karin Melanie Rohrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annika Erbacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Friederike Gieseke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carl-Philipp Schwarze
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rupert Handgretinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael Hofbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gunter Kerst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michaela Döring.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Döring, M., Rohrer, K.M., Erbacher, A. et al. Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation. Ann Hematol 94, 265–273 (2015). https://doi.org/10.1007/s00277-014-2185-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2185-y

Keywords

Search

Navigation